Please login to the form below

Not currently logged in
Email:
Password:

Stephen Eck joins Aravive Biologics

He takes up president and CEO positions

Aravive Biologics has appointed Stephen Eck as its new CEO and president at a time when the company is preparing to advance its lead drug candidate Aravive-S6 into human clinical testing.

Eck has served a number of global pharmaceutical companies in senior roles, including Eli Lilly and Pfizer, and most recently at Astellas Pharma as vice president of oncology medical sciences.

He said: “I am very excited to be joining Aravive at this point in the company’s development.

"I look forward to helping Aravive realise the full potential that I believe Gas6/AXL inhibition can bring to the treatment of cancer.”

Eck also serves on the board of directors of Texas-based life sciences company Luminex Corporation, he is a fellow of the American Association for the Advancement of Science and is chairman of the board of directors of the Personalised Medicine Coalition.

Ray Tabibiazar, founding president and CEO of Aravive, said: “Stephen has an impressive track-record of oncology drug and biomarker development at prominent pharmaceutical companies, as well as a close relationship to Houston’s M.D Anderson Cancer Centre as a member of the Advisory Board for their oncology Moonshot Programme.

“We welcome his expertise and leadership to the Aravive team.”

Eck succeeds Ray Tabibiazar who will remain as chairman of the company’s board of directors.

12th May 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics